Mortality-associated factors in a cohort of children with ventilator-associated pneumonia in a Latin American pediatric hospital

Main Article Content

Omar Eugenio Naveda Romero

Abstract

Background: Bearing in mind that ventilator-associated pneumonia (VAP) is the second most common healthcare-associated infection, it is important to identify factors related to its mortality, even more so in countries with limited resources. Objective: to determine risk factors for mortality due to VAP. Methods: prospective simple cohort study conducted between January 2017 and December 2020 that included children between 1 month and 14 years. Demographic variables, the severity of admission, type of VAP, causative germs, indications for ventilation, comorbidities, and medical interventions were related to mortality due to VAP. The diagnosis of VAP was made based on the 2013 CDC definition. Results: 46 children with VAP were included in the analysis. Mortality was 34.8 %. The factors associated with mortality were: pSOFA (Pediatric Sequential Organ Failure Assessment Score) in the first 24 hours of admission greater than 7 points (3.3 % vs. 50 %; OR: 29.0; CI-95 % [3.1 – 267 .4]; p < 0.0001), Enterobacter cloacae infection (3.3 % vs. 37.5 %; OR: 17.1; 95 % CI [1.9 – 162.7]; p = 0.002) and VAT (ventilator-associated tracheobronchitis ) (16.7 % vs. 50 %; OR: 5.0; 95 % CI [1.3 – 19.7]; p = 0.017). Shock, multiple organ dysfunction syndrome (MODS), and sepsis were also associated. Conclusions: pSOFA, Enterobacter cloacae infection, VATS, shock, SDMO, and sepsis were associated with mortality in children with VAP.

Downloads

Download data is not yet available.

Article Details

How to Cite
Naveda Romero, O. E. (2022). Mortality-associated factors in a cohort of children with ventilator-associated pneumonia in a Latin American pediatric hospital. Pediatría, 55(3), 127–134. https://doi.org/10.14295/rp.v55i3.365
Section
Originals

References

Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, Cardo DM: Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122:160–166. DOI: https://doi.org/10.1177/003335490712200205

Vijay G, Mandal A, Sankar J, Kapil A, Lodha R, Kabra SK. Ventilator Associated Pneumonia in Pediatric Intensive Care Unit: Incidence, Risk Factors and Etiological Agents. Indian J Pediatr. 2018;85(10):861-866. DOI: https://doi.org/10.1007/s12098-018-2662-8

Gupta S, Boville BM, Blanton R, Lukasiewicz B, Wincek J, Bai C, et al. A multicentered prospective analysis of diagnosis, risk factors, and outcomes associated with pediatric ventilator-associated pneumonia. Pediatr Crit Care Med. 2015;16:65-8. DOI: https://doi.org/10.1097/PCC.0000000000000338

Beardsley AL, Nitu ME, Cox EG, Benneyworth BD. An evaluation of various ventilator-associated infection criteria in a PICU. Pediatr Crit Care Med 2016; 17: 73-7. DOI: https://doi.org/10.1097/PCC.0000000000000569

Valdez JA, Hernández HG, González N, Cravioto P. Costo de la neumonía asociada a ventilador en la unidad de terapia intensiva pediátrica Rev Latin Infect Pediatr. 2017;30(2): 62-67.

Mourani PM, Sontag MK. Ventilator-Associated Pneumonia in Critically Ill Children: A New Paradigm. Pediatr Clin North Am. 2017; 64:1039–1056. DOI: https://doi.org/10.1016/j.pcl.2017.06.005

Naveda O. Factores de riesgo para el desarrollo de neumonía asociada al ventilador: un estudio de casos y controles. Pediatr. (Asunción). 2022;49(1):46-56. DOI: https://doi.org/10.31698/ped.49012022007

Branch-Elliman W, Wright SB, Howell MD. Determining the ideal strategy for ventilator-associated pneumonia prevention. Cost-benefit analysis. Am J Respir Crit Care Med. 2015; 192:57-63. DOI: https://doi.org/10.1164/rccm.201412-2316OC

Society AT, America IDS of. Guidelines for the Management of Adults with Hospital-Acquired, Ventilator-Associated, and Healthcare-Associated Pneumonia. Am J Respir Crit Care Med 2005;171:388–416. DOI: https://doi.org/10.1164/rccm.200405-644ST

Nseir S, Favory R, Jozefowicz E, Decamps F, Dewavrin F, Brunin G, et al; VAT Study Group. Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study. Crit Care. 2008; 12(3):R62.

Simpson VS, Bailey A, Higgerson RA, Christie LM. Ventilator-associated tracheobronchitis in a mixed medical/surgical pediatric ICU. Chest. 2013;144:32-38. DOI: https://doi.org/10.1378/chest.12-2343

CDC/National Healthcare Safety Network (NHSN). Surveillance for Ventilator-associated Events. Disponible en: https://www.cdc.gov/nhsn/acute-care-hospital/vae/index.html.

Matics TJ, Sanchez-Pinto LN. Adaptation and Validation of a Pediatric Sequential Organ Failure Assessment Score and Evaluation of the Sepsis-3 Definitions in Critically Ill Children. JAMA Pediatr. 2017;171(10):e172352.

Mohamed El-Mashad G, Said El-Mekkawy M, Helmy Zayan M. La escala pediátrica de evaluación del fallo multiorgánico secuencial (pSOFA): una nueva escala de predicción de la mortalidad en la unidad de cuidados intensivos pediátricos. An Pediatr (Barc). 2020;92(5): 277 – 285. DOI: https://doi.org/10.1016/j.anpedi.2019.05.018

López-Pueyo MJ, Barcenilla-Gaite F, Amaya-Villar R, Garnacho-Montero J. Multirresistencia antibiótica en unidades de críticos. Med. Intensiva. 2011;35(1): 41-53. DOI: https://doi.org/10.1016/j.medin.2010.07.011

The Pediatric Acute Lung Injury Consensus Conference Group. Pediatric acute respiratory distres syndrome: consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med. 2015; 16(5):428-39. DOI: https://doi.org/10.1097/PCC.0000000000000350

Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of Health caree associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008; 36:309e32. DOI: https://doi.org/10.1016/j.ajic.2008.03.002

Kidney Disease Improving Global Outcomes (KDIGO). Acute kidney injury work group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012; Suppl 2:1-138.

Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definition for nosocomial infections. In: Olmsted RN, ed. Infection Control and Applied Epidemiology: Principle and Practice. St. Louis: Mosby; 2005:A1 – A20.

Cieza-Yamunaqué L, Coila-Paricahua E. Neumonía asociada a ventilación mecánica en la unidad de cuidados intensivos pediátricos de un hospital terciario, 2015 – 2018. Rev. Fac. Med. Hum. 2019; 19(3):19-26. DOI: https://doi.org/10.25176/RFMH.v19i3.2167

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315:801-810. DOI: https://doi.org/10.1001/jama.2016.0287

Schlapbach LJ, Straney L, Bellomo R, MacLaren G, Pilcher D. Prognostic accuracy of age-adapted SOFA, SIRS PELOD-2, and qSOFA for in-hospital mortalityamong children with suspected infection admitted to the intensive care unit. Intensive Care Med. 2018; 44:179-188. DOI: https://doi.org/10.1007/s00134-017-5021-8

Matics TJ, Sanchez-Pinto LN. Adaptation and validation of a Pediatric Sequential Organ Failure Assessment Score and evaluation of the Sepsis-3 definitions in critically ill children. JAMA Pediatr. 2017; 171: e172352. DOI: https://doi.org/10.1001/jamapediatrics.2017.2352

Kruger S, Frechen D, Ewig S. Prognosis of ventlator-associated pneumonia: What lies beneath. Eur Respir J. 2001; 37:486 – 488. DOI: https://doi.org/10.1183/09031936.00123610

Pérez M, Figueroa H, Mendoza M. Traqueobronquitis y neumonía asociada al ventilador: curso clínico, consecuencias y pronóstico. Avan Biomedi. 2019; 8(3):113 – 119.

Grgurich P, Hudcova J, Lei Y, Sawar A, Craven D. Diagnosis of ventilator-associate pneumona: Controversies and working toward a gold standard. Curr Opin Infect Dis. 2013; 26:140-150. DOI: https://doi.org/10.1097/QCO.0b013e32835ebbd0

Nseir S, Favory R, Jozefowicz E, Decamps F, Dewavrin F, Brunin G, et al. Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study. Crit Care. 2008; 12(3): R62. DOI: https://doi.org/10.1186/cc6890

Mazzatesta ML, Gona F, Stefani S. Enterobacter cloacae complex: Clinical impact and emerging antibiotic resistance. Future Microbiol. 2012;7:887–902. DOI: https://doi.org/10.2217/fmb.12.61

Ferry A, Plaisant F, Ginevra C, Dumont Y, Grando J, Claris O, et al. Enterobacter cloacae colonisation and infection in a neonatal intensive care unit: retrospective investigation of preventive measures implemented after a multiclonal outbreak. BMC Infect Dis. 2020;20: 682. DOI: https://doi.org/10.1186/s12879-020-05406-8

Sadigov A, Mamedova I, Mammmadov K. Ventilator-Associated Pneumonia and In-Hospital Mortality: Which Risk Factors may predict In-Hospital Mortality in Such Patients. J Lung Health Dis. 2019; 3(4):8-12. DOI: https://doi.org/10.29245/2689-999X/2019/4.1157

Rodríguez M, Sánchez LG. Neumonía asociada a la ventilación mecánica en la Unidad de Cuidados Intensivos. Rev Ciencias Médicas. 2016; 20(5):603-607.

Similar Articles

<< < 2 3 4 5 6 7 8 9 > >> 

You may also start an advanced similarity search for this article.